Litigation Details for Cubist Pharmaceuticals LLC v. Crane Pharmaceuticals LLC (D. Del. 2016)
✉ Email this page to a colleague
Cubist Pharmaceuticals LLC v. Crane Pharmaceuticals LLC (D. Del. 2016)
| Docket | ⤷ Subscribe | Date Filed | 2016-02-10 |
| Court | District Court, D. Delaware | Date Terminated | 2016-03-11 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Patents | 6,468,967; 6,852,689; 8,058,238; 8,129,342 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Cubist Pharmaceuticals LLC v. Crane Pharmaceuticals LLC
The small molecule drug covered by the patents cited in this case is ⤷ Subscribe .
Details for Cubist Pharmaceuticals LLC v. Crane Pharmaceuticals LLC (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-02-09 | 1 | 10. United States Patent No. 6,468,967 (“the ’967 patent”), entitled “Methods for Administration…CUBICIN® prior to the expiration of U.S. Patent Nos. 6,468,967; 6,852,689; 8,058,238; and 8,129,342. … Infringement of U.S. Patent No. 6,468,967 21. Plaintiff incorporates … 1. This is an action for patent infringement under the patent laws of the United States, Title…. 11. United States Patent No. 6,852,689 (“the ’689 patent”), entitled “Methods for Administration | External link to document | |
| 2016-02-09 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,468,967 B1; 6,852,689 B2; 8,058,238…2016 11 March 2016 1:16-cv-00072 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
